Chemoinformaics analysis of 2,3-diphenyl-1H-pyrrole
| Molecular Weight | 219.287 | nRot | 2 |
| Heavy Atom Molecular Weight | 206.183 | nRig | 23 |
| Exact Molecular Weight | 219.105 | nRing | 3 |
| Solubility: LogS | -3.743 | nHRing | 1 |
| Solubility: LogP | 1.686 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 2 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 13 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 17 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 17 |
| nHA | 0 | APOL | 36.4883 |
| nHD | 1 | BPOL | 13.6117 |
| QED | 0.435 |
| Synth | 3.573 |
| Natural Product Likeliness | 1.651 |
| NR-PPAR-gamma | 0.275 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.773 |
| Pgp-sub | 0.022 |
| HIA | 0.01 |
| CACO-2 | -5.223 |
| MDCK | 0.0000332 |
| BBB | 0.018 |
| PPB | 0.952081 |
| VDSS | 0.958 |
| FU | 0.0857972 |
| CYP1A2-inh | 0.596 |
| CYP1A2-sub | 0.748 |
| CYP2c19-inh | 0.08 |
| CYP2c19-sub | 0.062 |
| CYP2c9-inh | 0.78 |
| CYP2c9-sub | 0.638 |
| CYP2d6-inh | 0.224 |
| CYP2d6-sub | 0.159 |
| CYP3a4-inh | 0.194 |
| CYP3a4-sub | 0.175 |
| CL | 2.062 |
| T12 | 0.866 |
| hERG | 0.001 |
| Ames | 0.934 |
| ROA | 0.602 |
| SkinSen | 0.475 |
| Carcinogencity | 0.785 |
| EI | 0.619 |
| Respiratory | 0.441 |
| NR-Aromatase | 0.167 |
| Antiviral | No |
| Prediction | 0.715074 |